Israel’s Gamida Cell reported good results from Duke University trials of its NiCord blood cancer treatment.  Compared with 101 patients receiving ordinary umbilical cord blood, the 18 patients using NiCord had a lower mortality rate, less infections and less time in hospital post-transplantation.

http://www.globes.co.il/en/article-gamida-cell-further-positive-blood-cancer-trial-results-1001115578